Richard Torres Selected Research

Richard Torres Research Topics

3	Inflammation (Inflammations) 01/2021 - 08/2007
2	Liver Diseases (Liver Disease) 01/2021 - 01/2021
2	Fibrosis (Cirrhosis) 01/2019 - 04/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 07/2014
2	Neoplasms (Cancer) 01/2019 - 01/2015
2	Pain (Aches) 04/2009 - 08/2007
1	Hemophilia A (Haemophilia) 03/2022
1	Biliary Atresia 01/2021
1	Vascular Remodeling 01/2020
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020
1	Papilledema 01/2020
1	Retinal Degeneration 01/2020
1	Telangiectasis (Telangiectasia) 01/2020
1	Vascular Diseases (Vascular Disease) 01/2020
1	Retinal Neovascularization 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Necrosis 01/2019
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Cysts 10/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2015
1	Hepatitis 07/2014
1	Sialadenitis 07/2014
1	Lymphadenopathy 07/2014
1	Weight Loss (Weight Reduction) 07/2014
1	Dehydration (Water Stress) 03/2014
1	Lymphoma (Lymphomas) 12/2012
1	Arthritis (Polyarthritis) 02/2012
1	Virus Diseases (Viral Diseases) 12/2010
1	HIV Infections (HIV Infection) 12/2010
1	Hemorrhage 06/2009
1	von Willebrand Diseases (von Willebrand's Disease) 06/2009
1	Hyperalgesia 08/2007

3	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2010
2	AutoantibodiesIBA 01/2021 - 02/2012
2	von Willebrand FactorIBA 01/2020 - 06/2009
2	Peptides (Polypeptides)IBA 01/2015 - 12/2010
2	neuromedin UIBA 02/2012 - 08/2007
1	Valoctocogene RoxaparvovecIBA 03/2022
1	AutoantigensIBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	EndoglinIBA 01/2020
1	Glial Fibrillary Acidic ProteinIBA 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Alemtuzumab (Campath)FDA Link 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2018
1	CollagenIBA 04/2016
1	pigment epithelium-derived factorIBA 01/2015
1	Low Density Lipoprotein Receptor-Related Protein-6IBA 01/2015
1	CateninsIBA 01/2015
1	IpilimumabIBA 07/2014
1	teplizumabIBA 07/2014
1	Nucleic AcidsIBA 03/2014
1	CyclinsIBA 12/2012
1	CalciumIBA 02/2012
1	NeuropeptidesIBA 02/2012
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2010
1	Amino Acids FDA Link 12/2010
1	CytokinesIBA 04/2009
1	Interleukin-1beta (Interleukin 1 beta)IBA 04/2009
1	InflammasomesIBA 04/2009
1	Capsaicin (Zostrix)FDA Link 08/2007
1	Formaldehyde (Formol)FDA Link 08/2007
1	Freund's AdjuvantIBA 08/2007

2	Therapeutics 01/2021 - 01/2020